<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Regulatory approval on FinanClub</title>
    <link>https://finan.club/tags/regulatory-approval/</link>
    <description>Recent content in Regulatory approval on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Aug 2023 07:02:57 +0000</lastBuildDate><atom:link href="https://finan.club/tags/regulatory-approval/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>TEVA</title>
      <link>https://finan.club/us/teva/</link>
      <pubDate>Sat, 12 Aug 2023 07:02:57 +0000</pubDate>
      
      <guid>https://finan.club/us/teva/</guid>
      <description>score:20
Chances: Positive impact of new product launches on the Zacks Medical - Generic Drugs industry. Strong second-quarter results with beating estimates for earnings and sales. Prospects for brand name drugs, including migraine drug Ajovy, boosting revenue. Re-taking of the 200-day moving average by Teva stock after beating second-quarter estimates.</description>
    </item>
    
    <item>
      <title>JOBY</title>
      <link>https://finan.club/us/joby/</link>
      <pubDate>Sat, 12 Aug 2023 06:58:17 +0000</pubDate>
      
      <guid>https://finan.club/us/joby/</guid>
      <description>score:8
Chances: Release of operational and financial results for the second quarter, showcasing progress. Company&amp;rsquo;s focus on developing all-electric aircraft for commercial passenger service. Submission of Certification Plans to the FAA, marking progress towards aircraft certification. Annual release of Environmental, Social, Governance (ESG) report, highlighting responsible practices.</description>
    </item>
    
  </channel>
</rss>
